Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter's Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threat
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation, By type
6.1 Carbohydrate Adjuvants
6.2 Liposome Adjuvants
6.3 Bacteria derived Adjuvants
6.4 Adjuvant Emulsions
6.5 Tensoactive Adjuvants
6.6 Aluminium Salts
Chapter 7 Market Segmentation, By Route of Administration
7.1 intranasal
7.2 intradermal
7.3 oral
Chapter 8 Market Segmentation, By Mechanism of Action
8.1 vehicle adjuvants
8.2 carriers
8.3 active immunostimulants
Chapter 9 Market Segmentation, By Geography
9.1 North America
9.1.1 Introduction
9.1.2 United States
9.1.3 Canada
9.1.4 Mexico
9.1.5 Others
9.2 Europe
9.2.1 Introduction
9.2.2 U.K
9.2.3 Spain
9.2.4 Italy
9.2.5 France
9.2.6 Russia
9.2.7 Others
9.3 Asia-Pacific
9.3.1 Introduction
9.3.2 China
9.3.3 India
9.3.4 Japan
9.3.5 Australia
9.3.6 Others
9.4 South America
9.4.1 Introduction
9.4.2 Brazil
9.4.3 Argentina
9.4.4 Others
9.5 The Middle East & Africa
9.5.1 Introduction
9.5.2 South Africa
9.5.3 Others
Chapter 10 Competitive Landscape
10.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
10.2 Market Share Analysis
10.3 Strategies Adopted By Top Companies
Chapter 11 Company Profiles
11.1. Adjuvance Technologies, Inc
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Benchmarking
11.1.4. Strategic Initiative
11.2. Vaxliant
11.3. Adjuvatis
11.4. Novavax
11.5. Oz Biosciences
11.6. Seppic
11.7. Sigma Aldrich
11.8. Invivogen
11.9. Brenntag Biosector
11.10. CSL Limited
11.11. Agenus, Inc.
11.12. SPI Pharma, Inc.
11.13. Avanti Polar Lipids, Inc.
11.14. MVP Laboratories, Inc.
11.15. OZ Biosciences
Chapter 12 Market Estimates and Forecast
12.1 Market Estimates and Forecast 2018-2024(USD Million)
12.1.1 Market Estimation and Forecast by Type 2018-2024 (USD Million)
12.1.1 Market Estimation and Forecast by Route of Administration 2018-2024 (USD Million)
12.1.1 Market Estimation and Forecast by Mechanism of Action 2018-2024 (USD Million)
12.1.2 Market Estimates and Forecast by Geography 2018-2024 (USD Million)
Chapter 13 Market Insights
13.1 Insights of Industry Experts
13.2 Analyst Opinion (Market Understanding)
13.3 Investment Opportunities
Chapter 14 Appendix
14.1 List of Tables
14.2 List of Figures
